Fri, Nov 28, 2014, 2:12 PM EST - U.S. Markets closed early today


% | $
Quotes you view appear here for quick access.

CryoLife Inc. Message Board

  • dlhild Feb 18, 2013 10:59 PM Flag


    Three Years of Historical BioGlue sales (check the numbers first yourself though):

    Q1 2010 $11,912,000
    Q2 2010 $12,261,000
    Q3 2010 $11,046,000
    Q4 2010 $12,164,000

    Total 2010 $47,383,000

    Q1 2011 $11,974,000
    Q2 2011 $12,772,000
    Q3 2011 $12,190,000
    Q4 2011 $12,519,000

    Total 2011 $49,455,000, 4% YoY growth

    Q1 2012 $13,696,000
    Q2 2012 $13,437,000
    Q3 2012 $12,725,000
    Q4 2012 $13,353,000

    Total 2012 $53,211,000, 8% YoY growth (Excellent YoY growth)

    I would guess that the BioGlue cost center will generate roughly $19 million EDITDA during 2013. Assuming that CRY can continue to slowly grow this market, this product line is and will remain EXTREMELY profitable. However, IF someone would ever aggressively and effectively attack this market, it would be a serious problem for CRY. Right now though, I don’t see this type of threat on CRY’s horizon.

    BioFoam sales seem to be included in the above numbers.

    Conclusion: Draw your own conclusions. You Amigo have to sort things out for yourself, as you are responsible for doing your own due diligence.

10.10-0.02(-0.20%)Nov 28 1:02 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.